aav2 Search Results


95
PackGene Biotech lnc aav2 cas9
Aav2 Cas9, supplied by PackGene Biotech lnc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aav2/pmc12930510-150-8-14?v=PackGene+Biotech+lnc
Average 95 stars, based on 1 article reviews
aav2 cas9 - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

86
Obio Technology Corp Ltd aav2
Aav2, supplied by Obio Technology Corp Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aav2/pm41922345-218-22-27?v=Obio+Technology+Corp+Ltd
Average 86 stars, based on 1 article reviews
aav2 - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

93
Addgene inc aav2 tetbow vectors
Aav2 Tetbow Vectors, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aav2/10__7554_slash_elife__40350-338-0-7?v=Addgene+inc
Average 93 stars, based on 1 article reviews
aav2 tetbow vectors - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

90
Addgene inc addgene plasmid repository
Addgene Plasmid Repository, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aav2/pm29097684-417-8-8?v=Addgene+inc
Average 90 stars, based on 1 article reviews
addgene plasmid repository - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

91
OriGene anti aav vp1 vp2 vp3 rabbit polyclonal
Anti Aav Vp1 Vp2 Vp3 Rabbit Polyclonal, supplied by OriGene, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aav2/10__21203_slash_rs__3__rs___1895370_slash_v1-263-27-31?v=OriGene
Average 91 stars, based on 1 article reviews
anti aav vp1 vp2 vp3 rabbit polyclonal - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

93
Addgene inc plasmid phobos ca citrine
(A) Left: Engineering strategy yielding Aion and <t>Phobos</t> CADN , two new blue-shifted, step-function ACRs with temporally extended conducting states. Mutation of the D156 residue to either C or N (yielding Aion and Phobos CADN , respectively) greatly slows down the closing kinetics of the ACRs compared to its parental construct <t>Phobos</t> <t>CA</t> . The generated variants are highlighted by a black frame. Right: Schematic of Aion indicating point mutations (triangles) at the relative position within the respective transmembrane helix. (B) Representative photocurrent traces of the slow-cycling ACRs Phobos CA , Aion, Phobos CADN , and Gt ACR1 CA activated by a short 20 ms light pulse at indicated wavelengths and irradiance of 3.35 mW/mm 2 (460nm) and 3.14 mW/mm 2 (505 nm). (C) Left: quantification of peak photocurrent ( I p ) and photocurrent 30 s post illumination ( I 30s ) for each ACR. Right: photocurrent ratio at 30 s compared to the peak. (D) Normalized photocurrent after light shutoff. (E) Closing time constants (τ off ) for each ACR. For (C) and (E), black lines correspond to mean values ± SEM, and circles are single measurement data points (n PhobosCA = 5 -6 cells, nAion = 5 - 10 cells, n PhobosCADN = 8 - 9 cells, n Gt ACR1CA = 6 cells). Kruskal- Wallis test with Dunn’s multiple comparisons test, *p < 0.05, **p < 0.01, ***p < 0.001.
Plasmid Phobos Ca Citrine, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aav2/bio_rxiv__2022__02__25__481932-219-16-22?v=Addgene+inc
Average 93 stars, based on 1 article reviews
plasmid phobos ca citrine - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

a1  (OriGene)
91
OriGene a1
(A) Left: Engineering strategy yielding Aion and <t>Phobos</t> CADN , two new blue-shifted, step-function ACRs with temporally extended conducting states. Mutation of the D156 residue to either C or N (yielding Aion and Phobos CADN , respectively) greatly slows down the closing kinetics of the ACRs compared to its parental construct <t>Phobos</t> <t>CA</t> . The generated variants are highlighted by a black frame. Right: Schematic of Aion indicating point mutations (triangles) at the relative position within the respective transmembrane helix. (B) Representative photocurrent traces of the slow-cycling ACRs Phobos CA , Aion, Phobos CADN , and Gt ACR1 CA activated by a short 20 ms light pulse at indicated wavelengths and irradiance of 3.35 mW/mm 2 (460nm) and 3.14 mW/mm 2 (505 nm). (C) Left: quantification of peak photocurrent ( I p ) and photocurrent 30 s post illumination ( I 30s ) for each ACR. Right: photocurrent ratio at 30 s compared to the peak. (D) Normalized photocurrent after light shutoff. (E) Closing time constants (τ off ) for each ACR. For (C) and (E), black lines correspond to mean values ± SEM, and circles are single measurement data points (n PhobosCA = 5 -6 cells, nAion = 5 - 10 cells, n PhobosCADN = 8 - 9 cells, n Gt ACR1CA = 6 cells). Kruskal- Wallis test with Dunn’s multiple comparisons test, *p < 0.05, **p < 0.01, ***p < 0.001.
A1, supplied by OriGene, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aav2/pm36996872-802-34-35?v=OriGene
Average 91 stars, based on 1 article reviews
a1 - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

91
OriGene anti aav vp1 vp2
(A) Left: Engineering strategy yielding Aion and <t>Phobos</t> CADN , two new blue-shifted, step-function ACRs with temporally extended conducting states. Mutation of the D156 residue to either C or N (yielding Aion and Phobos CADN , respectively) greatly slows down the closing kinetics of the ACRs compared to its parental construct <t>Phobos</t> <t>CA</t> . The generated variants are highlighted by a black frame. Right: Schematic of Aion indicating point mutations (triangles) at the relative position within the respective transmembrane helix. (B) Representative photocurrent traces of the slow-cycling ACRs Phobos CA , Aion, Phobos CADN , and Gt ACR1 CA activated by a short 20 ms light pulse at indicated wavelengths and irradiance of 3.35 mW/mm 2 (460nm) and 3.14 mW/mm 2 (505 nm). (C) Left: quantification of peak photocurrent ( I p ) and photocurrent 30 s post illumination ( I 30s ) for each ACR. Right: photocurrent ratio at 30 s compared to the peak. (D) Normalized photocurrent after light shutoff. (E) Closing time constants (τ off ) for each ACR. For (C) and (E), black lines correspond to mean values ± SEM, and circles are single measurement data points (n PhobosCA = 5 -6 cells, nAion = 5 - 10 cells, n PhobosCADN = 8 - 9 cells, n Gt ACR1CA = 6 cells). Kruskal- Wallis test with Dunn’s multiple comparisons test, *p < 0.05, **p < 0.01, ***p < 0.001.
Anti Aav Vp1 Vp2, supplied by OriGene, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aav2/pm36996872-803-31-35?v=OriGene
Average 91 stars, based on 1 article reviews
anti aav vp1 vp2 - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

90
OriGene bm5012su
(A) Left: Engineering strategy yielding Aion and <t>Phobos</t> CADN , two new blue-shifted, step-function ACRs with temporally extended conducting states. Mutation of the D156 residue to either C or N (yielding Aion and Phobos CADN , respectively) greatly slows down the closing kinetics of the ACRs compared to its parental construct <t>Phobos</t> <t>CA</t> . The generated variants are highlighted by a black frame. Right: Schematic of Aion indicating point mutations (triangles) at the relative position within the respective transmembrane helix. (B) Representative photocurrent traces of the slow-cycling ACRs Phobos CA , Aion, Phobos CADN , and Gt ACR1 CA activated by a short 20 ms light pulse at indicated wavelengths and irradiance of 3.35 mW/mm 2 (460nm) and 3.14 mW/mm 2 (505 nm). (C) Left: quantification of peak photocurrent ( I p ) and photocurrent 30 s post illumination ( I 30s ) for each ACR. Right: photocurrent ratio at 30 s compared to the peak. (D) Normalized photocurrent after light shutoff. (E) Closing time constants (τ off ) for each ACR. For (C) and (E), black lines correspond to mean values ± SEM, and circles are single measurement data points (n PhobosCA = 5 -6 cells, nAion = 5 - 10 cells, n PhobosCADN = 8 - 9 cells, n Gt ACR1CA = 6 cells). Kruskal- Wallis test with Dunn’s multiple comparisons test, *p < 0.05, **p < 0.01, ***p < 0.001.
Bm5012su, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aav2/pmc04135950-94-93-89?v=OriGene
Average 90 stars, based on 1 article reviews
bm5012su - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

86
Pfizer Inc pennsylvania vector core aav2
(A) Left: Engineering strategy yielding Aion and <t>Phobos</t> CADN , two new blue-shifted, step-function ACRs with temporally extended conducting states. Mutation of the D156 residue to either C or N (yielding Aion and Phobos CADN , respectively) greatly slows down the closing kinetics of the ACRs compared to its parental construct <t>Phobos</t> <t>CA</t> . The generated variants are highlighted by a black frame. Right: Schematic of Aion indicating point mutations (triangles) at the relative position within the respective transmembrane helix. (B) Representative photocurrent traces of the slow-cycling ACRs Phobos CA , Aion, Phobos CADN , and Gt ACR1 CA activated by a short 20 ms light pulse at indicated wavelengths and irradiance of 3.35 mW/mm 2 (460nm) and 3.14 mW/mm 2 (505 nm). (C) Left: quantification of peak photocurrent ( I p ) and photocurrent 30 s post illumination ( I 30s ) for each ACR. Right: photocurrent ratio at 30 s compared to the peak. (D) Normalized photocurrent after light shutoff. (E) Closing time constants (τ off ) for each ACR. For (C) and (E), black lines correspond to mean values ± SEM, and circles are single measurement data points (n PhobosCA = 5 -6 cells, nAion = 5 - 10 cells, n PhobosCADN = 8 - 9 cells, n Gt ACR1CA = 6 cells). Kruskal- Wallis test with Dunn’s multiple comparisons test, *p < 0.05, **p < 0.01, ***p < 0.001.
Pennsylvania Vector Core Aav2, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aav2/pm28467931-450-82-99?v=Pfizer+Inc
Average 86 stars, based on 1 article reviews
pennsylvania vector core aav2 - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

Image Search Results


(A) Left: Engineering strategy yielding Aion and Phobos CADN , two new blue-shifted, step-function ACRs with temporally extended conducting states. Mutation of the D156 residue to either C or N (yielding Aion and Phobos CADN , respectively) greatly slows down the closing kinetics of the ACRs compared to its parental construct Phobos CA . The generated variants are highlighted by a black frame. Right: Schematic of Aion indicating point mutations (triangles) at the relative position within the respective transmembrane helix. (B) Representative photocurrent traces of the slow-cycling ACRs Phobos CA , Aion, Phobos CADN , and Gt ACR1 CA activated by a short 20 ms light pulse at indicated wavelengths and irradiance of 3.35 mW/mm 2 (460nm) and 3.14 mW/mm 2 (505 nm). (C) Left: quantification of peak photocurrent ( I p ) and photocurrent 30 s post illumination ( I 30s ) for each ACR. Right: photocurrent ratio at 30 s compared to the peak. (D) Normalized photocurrent after light shutoff. (E) Closing time constants (τ off ) for each ACR. For (C) and (E), black lines correspond to mean values ± SEM, and circles are single measurement data points (n PhobosCA = 5 -6 cells, nAion = 5 - 10 cells, n PhobosCADN = 8 - 9 cells, n Gt ACR1CA = 6 cells). Kruskal- Wallis test with Dunn’s multiple comparisons test, *p < 0.05, **p < 0.01, ***p < 0.001.

Journal: bioRxiv

Article Title: Temporally extended and reversible neuronal silencing with Aion

doi: 10.1101/2022.02.25.481932

Figure Lengend Snippet: (A) Left: Engineering strategy yielding Aion and Phobos CADN , two new blue-shifted, step-function ACRs with temporally extended conducting states. Mutation of the D156 residue to either C or N (yielding Aion and Phobos CADN , respectively) greatly slows down the closing kinetics of the ACRs compared to its parental construct Phobos CA . The generated variants are highlighted by a black frame. Right: Schematic of Aion indicating point mutations (triangles) at the relative position within the respective transmembrane helix. (B) Representative photocurrent traces of the slow-cycling ACRs Phobos CA , Aion, Phobos CADN , and Gt ACR1 CA activated by a short 20 ms light pulse at indicated wavelengths and irradiance of 3.35 mW/mm 2 (460nm) and 3.14 mW/mm 2 (505 nm). (C) Left: quantification of peak photocurrent ( I p ) and photocurrent 30 s post illumination ( I 30s ) for each ACR. Right: photocurrent ratio at 30 s compared to the peak. (D) Normalized photocurrent after light shutoff. (E) Closing time constants (τ off ) for each ACR. For (C) and (E), black lines correspond to mean values ± SEM, and circles are single measurement data points (n PhobosCA = 5 -6 cells, nAion = 5 - 10 cells, n PhobosCADN = 8 - 9 cells, n Gt ACR1CA = 6 cells). Kruskal- Wallis test with Dunn’s multiple comparisons test, *p < 0.05, **p < 0.01, ***p < 0.001.

Article Snippet: Phobos CA mutants (D156C/Aion, D156N, D156S, D156H) were generated by site-directed mutagenesis of our previously reported plasmid Phobos CA -citrine ( ) (Addgene #98218).

Techniques: Mutagenesis, Residue, Construct, Generated

Maximum-intensity projection images of two-photon stacks showing expression of Phobos CA -D156C ( A ), Phobos CA -D156N ( B ), Phobos CA -D156S ( C ), and Phobos CA -D156H ( D ) in CA1 pyramidal neurons after single-cell electroporation in organotypic hippocampal slice cultures. Fluorescence intensity is shown as inverted gray values. Opsin-citrine fluorescence (top row) was mainly localized at the plasma membrane in Phobos CA -D156C (A) and Phobos CA -D156N (B) expressing cells. However, Phobos CA -D156S (C) and Phobos CA -D156H (D) expressing neurons showed poor trafficking and strong protein accumulation in the soma. mCerulean was co-electroporated together with all opsin variants and served as a morphology marker (bottom row).

Journal: bioRxiv

Article Title: Temporally extended and reversible neuronal silencing with Aion

doi: 10.1101/2022.02.25.481932

Figure Lengend Snippet: Maximum-intensity projection images of two-photon stacks showing expression of Phobos CA -D156C ( A ), Phobos CA -D156N ( B ), Phobos CA -D156S ( C ), and Phobos CA -D156H ( D ) in CA1 pyramidal neurons after single-cell electroporation in organotypic hippocampal slice cultures. Fluorescence intensity is shown as inverted gray values. Opsin-citrine fluorescence (top row) was mainly localized at the plasma membrane in Phobos CA -D156C (A) and Phobos CA -D156N (B) expressing cells. However, Phobos CA -D156S (C) and Phobos CA -D156H (D) expressing neurons showed poor trafficking and strong protein accumulation in the soma. mCerulean was co-electroporated together with all opsin variants and served as a morphology marker (bottom row).

Article Snippet: Phobos CA mutants (D156C/Aion, D156N, D156S, D156H) were generated by site-directed mutagenesis of our previously reported plasmid Phobos CA -citrine ( ) (Addgene #98218).

Techniques: Expressing, Electroporation, Fluorescence, Clinical Proteomics, Membrane, Marker

( A ) Representative current traces of kinetically modified Phobos CA variants and Gt ACR1 CA . ACR variants were illuminated with 500 ms (row 1-4) or 20 ms (last row) actinic light at indicated wavelengths, while termination of photocurrents was accelerated with orange or red light for 10 s as indicated. ( B ) and ( C ) temporally expanded photocurrent traces as shown in (A) showing different modes of inactivation (B) and accelerated closing kinetics of Phobos CA variants (C). ( D ) Quantification of the residual photocurrent after orange or red-light application. While Gt ACR1 CA showed a 30 % photocurrent reduction when red light was applied 2 s post initial activation, application after 30 s caused partial re-opening of the channel. Phobos CA variants could be fully closed by orange light. (E) Quantification of the accelerated channel closing of Phobos CA variants with orange light.

Journal: bioRxiv

Article Title: Temporally extended and reversible neuronal silencing with Aion

doi: 10.1101/2022.02.25.481932

Figure Lengend Snippet: ( A ) Representative current traces of kinetically modified Phobos CA variants and Gt ACR1 CA . ACR variants were illuminated with 500 ms (row 1-4) or 20 ms (last row) actinic light at indicated wavelengths, while termination of photocurrents was accelerated with orange or red light for 10 s as indicated. ( B ) and ( C ) temporally expanded photocurrent traces as shown in (A) showing different modes of inactivation (B) and accelerated closing kinetics of Phobos CA variants (C). ( D ) Quantification of the residual photocurrent after orange or red-light application. While Gt ACR1 CA showed a 30 % photocurrent reduction when red light was applied 2 s post initial activation, application after 30 s caused partial re-opening of the channel. Phobos CA variants could be fully closed by orange light. (E) Quantification of the accelerated channel closing of Phobos CA variants with orange light.

Article Snippet: Phobos CA mutants (D156C/Aion, D156N, D156S, D156H) were generated by site-directed mutagenesis of our previously reported plasmid Phobos CA -citrine ( ) (Addgene #98218).

Techniques: Modification, Activation Assay